WO2001033193A9 - Automated plant extraction method and arrays for high throughput screening - Google Patents
Automated plant extraction method and arrays for high throughput screeningInfo
- Publication number
- WO2001033193A9 WO2001033193A9 PCT/US2000/030195 US0030195W WO0133193A9 WO 2001033193 A9 WO2001033193 A9 WO 2001033193A9 US 0030195 W US0030195 W US 0030195W WO 0133193 A9 WO0133193 A9 WO 0133193A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- isolate
- plant
- solvent
- chromatography
- extract
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/10—Devices for withdrawing samples in the liquid or fluent state
- G01N1/18—Devices for withdrawing samples in the liquid or fluent state with provision for splitting samples into portions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00695—Synthesis control routines, e.g. using computer programs
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/007—Simulation or vitual synthesis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00702—Processes involving means for analysing and characterising the products
- B01J2219/00707—Processes involving means for analysing and characterising the products separated from the reactor apparatus
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/0074—Biological products
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0893—Geometry, shape and general structure having a very large number of wells, microfabricated wells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N2001/021—Correlating sampling sites with geographical information, e.g. GPS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N2030/009—Extraction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/062—Preparation extracting sample from raw material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/24—Automatic injection systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/38—Flow patterns
- G01N30/46—Flow patterns using more than one column
- G01N30/466—Flow patterns using more than one column with separation columns in parallel
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/80—Fraction collectors
- G01N30/82—Automatic means therefor
Definitions
- the invention applies to the extraction, separation, isolation, distribution, handling, and biological screening of extracts and isolated compounds from plants and other biological materials.
- the invention optimizes processes involved in properly preparing plant extracts or isolated compounds from plant extracts or plants for the screening of biological activity including liquid extraction, removal of interferences, automated distribution and solid phase extraction, purification, delivery and packaging, and high throughput screening.
- a typical plant may contain well over 5,000 unique chemical compounds in a wide range of concentrations, about 500-1000 of which are in a quantity detectable by current mass spectrometric methods.
- performing an assay on a crude plant extract is not typically efficient.
- the biological activity of minor components are frequently masked by the activity of major components in the extract.
- the biological activity detected in a crude extract may reflect only the activity of the 10-15 major or most prevalent components.
- This invention solves problems in the prior art by removing interferences as a discrete step in preparing plant isolates for biological screening.
- This invention differs from the prior art in modifications which were previously not known or suggested by providing arrays of isolates of natural products generated in a logical manner that includes scientifically useful information in an associated data array.
- the invention also provides advantages that were not previously appreciated by generating a catalog of related plant isolates and an associated virtual catalog of data corresponding to those isolates in a format suitable for efficient and effective high throughput screening. Results obtained using the invention also provide for rapid isolation and structural elucidation of therapeutically useful compounds.
- This invention succeeds at providing selective fractionation of plant material where previous efforts such as selective liquid extraction have failed.
- This invention solves previously unrecognized problems with liquid extraction of plant biomass.
- This invention solves a problem previously thought to be insoluble, that of harnessing plant biodiversity with the high throughput approaches of combinatorial chemistry and automated screening.
- Combinatorial chemists have typically viewed plant material as too complex to use as starting material for the structural variation that is typical in generating combinatorial libraries.
- the invention permits the study of a vast new array of phytochemical structures and their evaluation for bio-activity such as in treating diseases or providing useful agricultural traits.
- This invention solves further problems associated with the application of automated purification systems to plant extracts.
- the purification system utilizes the prior separation data to determine subsequent purification steps. For example, if a peak comprising multiple compounds is detected, the system may identify the previous solvent gradient used for the separation and chromatograph that fraction using a more shallow gradient to resolve the peak into individual compounds.
- This invention has aspects in the mature art of plant fractionation and other aspects in the crowded field of high throughput screening, none of which aspects had been combined before.
- This invention omits elements employed in the prior art, including selective liquid extraction into different solvent fractions, without loss of ability and indeed with enhanced performance by providing higher concentrations of relevant phytochemicals.
- the invention fills a long felt need for a method to rapidly isolate minor components from biological source materials in a form free from major components for testing biological activity of the minor components.
- minor components are isolated in forms that provide concentrations for testing that are at least within an order of magnitude of the concentration of major components in the crude extracts.
- the biological activity of minor components may be readily assessed, greatly increasing the discovery rate for these compounds.
- this invention is a method of doing business that includes accessing an electronic catalog on a website and purchasing frozen tissue and natural product derivatives for scientific or commercial purposes.
- the invention is a previously unobtainable method to allow rapid access to pure, previously unknown natural product derivatives by enabling scientists, researchers and business managers to identify and order natural products. The method is superior to any comparable process known in the prior art.
- a principal object of the present invention is a complete and general method that is more efficient and produces a much greater number of isolated compounds per plant than currently used by those skilled in the art.
- Another object of the invention is a procedure that combines a limited and focused liquid extraction procedure with chromatographic processes to isolate and concentrate isolated phytochemicals.
- the invention is particularly amenable for use in the high throughput screening of plant samples by biological assays.
- Another object of the present invention is an improved configuration for organizing plant extracts or isolated compounds from plant extracts or plants before analysis to expedite the screening in biological assays and the subsequent isolation and identification of an active compound.
- the method and product of the method are superior to anything known to those skilled in the art.
- the extraction protocol is thorough so that it provides a comprehensive catalog of the potentially bioactive phytochemicals in a plant sample, and it permits removal of non-selectively bio-active interferences from the extracts, thus producing a population of the potentially selectively bio- active phytochemicals.
- Fractionation according to the invention surprisingly reduces problems in high throughput bio-assay screening, such as masking of activities of one chemical by another, and allosteric regulation of receptors by multiple components.
- the invention produces extracts having a higher yield of phytochemicals of interest as compared to conventional methods, both in terms of chemical diversity and higher total mass.
- the extraction and chromatography steps solve problems with solubility of phytochemicals, because in the course of extracting and fractionating the phytochemicals they are put in solution under known conditions.
- This facilitates the design of the screening system (e.g. solvents to use) and greatly accelerates preparation and purification of a compound that provides a hit.
- the invention provides a solubility and fractionation profile for each isolate that can be used both as an initial indicator of the chemical nature of the isolated fraction, which can help as a first step in elucidating the structure of the compound, and the fractionation data can be used to refractionate a larger quantity of the material for further analysis in the event it becomes a lead by virtue of a positive result in a bio-assay.
- the small analytical scale fractionation and chromatography producing a small mass isolate can be readily scaled up with more plant material and a larger column to provide the same isolate in larger yield. This will shorten the time needed to design a purification procedure and hasten structure elucidation.
- the invention may further use data accumulated with each fraction collected to further purify multi-component fractions.
- an appropriate algorithm may control further separation and fractionation based, first, on a determination by MS, DAD or other detection mechanism that multiple compounds are present, and second, on the previously utilized chromatographic steps.
- the further separation may involve reapphcation of a previously utilized technique or a new technique.
- Reapphcation of a previous technique may include, for example, reapplying a gradient at a more shallow slope.
- New techniques include, for example, using a different solvent system or a different chromatography column.
- This invention satisfies a long felt need for an efficient way to separate the potentially selective bio-active biochemicals in a wide variety of different types of biomass with associated data useful in further research on the compounds.
- the present invention pertains to the optimization of processes involved in preparing plant extracts or isolated compounds from plant extracts or plants for the screening of biological activity including liquid extraction, removal of interferences, automated distribution and solid phase extraction, isolation, delivery and packaging, and high throughput screening.
- dried plant material is ground by a suitable mill to a fine powder.
- a systematic liquid extraction procedure is followed by utilizing a sequence of two solvents or system of solvents with different selectivity properties for extremely lipophilic and lipophilic to hydrophilic compounds.
- the solvents are separated from any insoluble biomass and evaporated to result in two solvent fractionated plant extracts.
- the plant extracts known to contain polyphenols or tannins are passed through a polyamide solid phase extraction column. All of the eluents are combined and the solvent is evaporated.
- the plant extracts suspected to contain fatty acids, phospholipids, tri- di and monoglycerides are passed through a C2, C4, or C6 column. All of the eluents are combined and the solvent is evaporated.
- the plant extracts are diluted in an appropriate amount of solvent and loaded onto the worktable of a liquid handling system.
- a computer program controls the liquid handling system and it aspirates and dispenses the plant extract solutions into solid phase extraction columns in an array located above a solid phase extraction apparatus located on the worktable.
- a computer program controls the entire solid phase extraction process including dispensing a solvent or a mixture of solvents to turning the vacuum on and off which pull the solvents through the sorbent of the column.
- a robotic manipulator arm places the 96 well microtiter collection plates into the solid phase extraction apparatus to collect all the eluent or a desired eluent.
- the RoMa removes the collected fractions in the 96 well microtiter plates from the solid phase extraction apparatus and puts them in a designated area on the worktable. The process repeats until all of the desired fractions are collected.
- a positive identification system on the worktable is controlled by a computer program and tracks the movements of all the vials and microtiter plates on the worktable. The sequence of events can be reviewed for accuracy.
- the solvent from the microtiter plates is removed from each well.
- a dried plant extract remains in each well that was used of the microtiter plates.
- the microtiter plates are sealed by someone skilled in the art and stored until analysis.
- the solvent in the wells of the microtiter plates may be kept, but it is preferred to be removed.
- the solvent fractionated and subsequently solid phase column fractionated and subsequently semi-preparative column isolated compounds from the plant are ready to be analyzed in an enzyme or cell based assay.
- the invention includes a method for generating a comprehensive ordered array of biological compounds suitable for high throughput screening of biological activity generated by thoroughly extracting a biological source material with at least one solvent, removing from the solvent extract(s) chemical interferences such as tannins, polyphenols, fatty acids, phospholipids and mono-, di- and tri-glycerides that may interfere with biological assays; chromatography by an automated system for handling samples and detecting the potentially selectively bio-active biochemicals of the source material in the eluent, and collecting the biochemicals in isolated fractions under control by the automated system. Each fraction has associated data sufficient to identify the biological source material, extraction solvent and chromatography conditions used by the automated system to obtain the fraction.
- the chromatography may be solid phase extraction and the isolates may be collected in microtiter plates.
- the biological source of material may be plants, fungi, bacteria and other microorganisms, marine organisms and sponges, and insects.
- the extracts may be subjected to additional chromatography steps to generate a set of pure compounds.
- the data associated with pure compounds may also include a digitally stored spectrum and the geographic location from which the sample was collected. All of the data is stored in a data system and is sufficient to regenerate an isolate or collect additional isolate, and provides an electronic shadow of the physical isolates.
- a robotic sample processor In a complete method for preparing plant extracts from any terrestrial plant for use in the high throughput screening of biological assays, a robotic sample processor is used to automate the aspiration and dispensing of solvent fractionated plant extracts.
- a robotic sample processor and a fully automated solid phase extraction apparatus are used to produce column fractionated plant extracts. All steps in the process are optimized by empirical data to result in a completely validated process. The method can process hundreds of plants per month which results in thousands of plant extracts more suitable for high throughout screening than those previously available.
- the invention provides a method for generating a comprehensive ordered array of biological compounds suitable for high throughput screening of biological activity, comprising the steps of: (a) thoroughly extracting a biological source material with at least one solvent to produce at least one solvent extract containing the potentially bio-active biochemicals of the source material; (b) removing from said at least one solvent extract interferences, comprising non-selectively bio-active compounds that interfere with biological assays, to produce at least one solvent extract comprising the potentially selectively bio-active biochemicals of the source material; (c) subjecting said at least one solvent extract from which interferences have been removed to chromatography by an automated system for handling samples, to produce a chromatography eluent; and (d) detecting the potentially selectively bio-active biochemicals of the source material in the eluent, and collecting the biochemicals in isolated fractions under control by the automated system; and for each fraction, associating data, said data being sufficient to identify the biological source material, extraction solvent and chromatography conditions used by the automated system to obtain the
- the chromatography is solid phase extraction, or HPLC
- the automated system e.g. comprises pumps, vacuums, valves, an autoinjector, at least one chromatography column, a computer, a detector, and a robot arm.
- fractions are collected in microtiter plates.
- the biological source may be selected from the group consisting of herbaceous plants, plant microorganisms such as algae, other microorganisms such as bacteria, marine organisms and sponges, and insects.
- the extraction protocol may have to be adapted, but remaining separative steps described below for plants may be suitable for similar extracts of other biological materials in similar solvent systems. Particular adaptations applicable to a variety of organisms can be readily determined by persons skilled in the art using routine optimization experimentation.
- the compounds that interfere with biological assays are typically tannins, polyphenols, fatty acids, phospholipids and mono-, di- and tri-glycerides and are removed by chromatography on a polyamide column, or a column having a lower alkyl medium having a carbon chain long enough to selectively interact with the non-polar fatty compounds.
- the solid phase extraction is typically conducted on a column selected from the group consisting of silica, diol, C2 -C18, and polymeric columns.
- the method may further comprise a plurality of steps (a) through (d), wherein each step
- step (a) is conducted with a different extracting solvent, and/or wherein different biological sources are used in each step (a), said different biological sources being selected from the group consisting of different plants, different parts of the same plant and different parts of different plants.
- the method may comprise the steps of simultaneously chromatographing a plurality of the fractions into subtractions with a second automated system wherein each subfraction contains no more than three individual compounds; obtaining the spectrum of each subfraction by use of a microdetector associated with the second automated system; digitally storing the spectrum of each subfraction; collecting the sub fractions in microtiter plates wherein each subfraction has an associated identifier that tracks the source of the extract, fraction and subfraction and correlates the digitally stored spectrum with the subfraction. If the digitally stored spectrum is a diode array spectrum and the subfraction is less than five to seven compounds, existing spectrum deconvolution software may be used to produce individual spectra specific for each of the compounds in the subfraction.
- the microdetector may be a photodiode array detector.
- An automated system comprises a plurality of independently operable and controllable chromatography systems.
- An array of purified extracts according to the invention is contained on a microtiter plate of at least 50 wells. Each subfraction may contain one principle compound.
- the invention provides an isolate in an array of M unique isolates derived from plant samples on a physical support, wherein M which is a function of P, S, E, F and A in which: P is the number of plants used to generate the extract samples; S is the number of samples obtained from different parts of each plant; E is the number of solvent extracts taken from each sample, F is the number of fractions obtained from each solvent extract, the fractions F being obtained by a first chromatography step; and
- A is the number of subtractions collected from a second chromatography step of each fraction.
- the first chromatography step preferably comprises the steps of: (a) subjecting the solvent extracts to solid phase extraction by an automated solid phase extraction system; and (b) collecting fractions in microtiter plates from the automated solid phase extraction, wherein fraction collection is controlled by the automated solid phase extraction system.
- the invention provides an ordered array comprising each of the M isolates, and associated data in a corresponding data array, wherein the data further identifies at least one of the taxonomic classification of the plant from which the extract is derived, the geographic location from which the plant was collected and the date on which the plant was collected.
- the method of the invention involves preparing isolates by a method comprising the steps of: (a) selecting P plants for extracting; (b) separating each of said P plants into S samples; (c) extracting each of said S samples with E solvents to generate E solvent extracts for each sample;
- the method for preparing the extract may further comprise the step of (g) subjecting each fraction F to a second chromatography and collecting from each fraction A subtractions.
- the invention also provides an array of isolate samples prepared by the steps of (a) thoroughly extracting a biological source material with at least one solvent to produce at least one solvent extract containing potentially bio-active biochemicals of the source material; (b) removing from said at least one solvent extract interferences, to produce at least one solvent extract comprising the potentially selectively bio-active biochemicals of the source material, said interferences comprising non-selectively bio-active compounds that interfere with biological assays; (c) subjecting said at least one solvent extract from which interferences have been removed to chromatography by an automated system for handling samples, to produce a chromatography eluent; and (d) collecting fractions from said eluent, and (e) distributing said fractions in an array of isolate samples, wherein each isolate sample in the array is present in an amount at a standardized assay concentration.
- Preparing the array of isolate samples may further include the steps of associating data with each sample sufficient to identify the biological source material, extraction solvent and chromatography conditions used by the automated system to obtain the sample.
- the data may also include a chromatographic spectrum of the isolate sample and a mass spectrum of the isolate sample.
- Each isolate sample preferably contains less than about 100 chemical compounds, more preferably less than about 15 chemical compounds and most preferably no more than about 5 compounds.
- the invention further comprises screening an ordered array for biological activity, and finding an isolate that has bioactivity, retrieving the data regarding the extraction solvent and chromatography conditions used by the system to obtain the fraction, and using the data to prepare a larger quantity of the isolate than was present in the array.
- this invention is a method for the distribution of plant isolates using an on-line catalog of plant extracts. This method has never been done before via the Internet or by any other mechanism, and has never been available to any person.
- This invention also relates to an electronic commerce software catalog system of natural product derivatives and a method of use. Further objectives and advantages will become apparent from a consideration of the description, drawings, and examples.
- Figure 1 is a schematic representation of liquid extraction.
- Figure 2 is a schematic representation of the removal of interferences.
- Figure 3 is a schematic representation of solid phase extraction as a first chromatography step.
- Figure 4 is a schematic representation of a second chromatography or purification step.
- Figure 5 is a schematic showing the sequence of steps from raw plant extracts to solid phase extracts to solid phase extraction fractions distributed on microtiter plates.
- Figure 6 is an example of a suitable liquid handling system.
- Figure 7 pictures the Robotic Manipulator Arm placing an array of 96 solid phase extraction columns and a vacuum plate over a microtiter plate in a preferred embodiment.
- Figure 8 is a diagram showing the fraction collector system that may comprise part of the solid phase extraction apparatus or the purification apparatus. The diagram explains the spectroscopic control of fraction collection, including monitoring of multiple wavelengths and setting of thresholds, and the presence of a diode array spectrum for each pure sample in the wells of the collection plate.
- Figure 9 is a diagram of the contents in wells of a collection plate containing isolates of the invention. The contents of three randomly selected wells is described.
- Figures 10-17 are illustrations of proposed webpages which, when viewed in sequence, show an example of a research transaction according to the data access and business method aspect of the invention.
- Figure 18 shows the layout of an array 100 of isolates in, for example, a microtiter plate and Liquid Chromatography/Mass Spectral (LC/MS) data obtained for a single isolate.
- Figure 19 shows TIC MS ES + LC/MS of typical isolates in an array.
- Figure 20 shows typical LC/MS data obtained when sample isolates are prepared.
- Natural products means products obtained from biological resources such as plants and animals. Natural products may be single compounds or complex mixtures derived from biological resources.
- Screening or “biological screening” shall mean any method used to detect biological activity of a sample. These terms include in vivo and in vitro testing, including bioassays.
- “Chemical interferences” or “interferences” generally refers to chemicals or other material present in natural products that may give rise to an inaccurate result during screening.
- a “hit” is a compound, fraction or other sample that gives a positive result in screening.
- “High throughput screening” means a screening method able to test a relatively large number of samples in a relatively short period of time. Generally, high throughput systems are automated and require little human intervention.
- “Ethnopharmacology” refers to a method of drug discovery where investigations focus on materials used in traditional or tribal medicine. Data that indicates pharmacological activity is generally anecdotal in nature and passed orally through generations.
- Progeny refers to compounds derived from a common source (e.g. biological resource). Progeny may be derived from the original source through one or more purification steps. “Fraction” means any sample that is part of a larger whole. “Isolates” shall mean the final sample suitable for testing. An isolate may be derived by one or many purification steps. A set of isolates arranged in an array of the invention may comprise progeny having a common ancestor source. All isolates are fractions. Fractions may be used as final samples and when used as such may be referred to as isolates. For the purposes herein, “pure” means sufficiently pure to avoid problems from competition, steric hindrance, and typically pure means that greater than about fifty percent of a sample, fraction or isolate is a single compound or chemical entity, although higher concentrations may be preferred.
- Automation or “automated system” is a means or apparatus that functions with a minimum of human intervention. Usually automation requires computer control. A system is considered automated even though it requires some human control, input and/or programming.
- Chromatography specifically includes normal and reverse phase systems, solid phase extraction and other methods conducted using a column, including high pressure systems and vacuum systems.
- the definition of chromatography as used herein is not otherwise limited, but has the general meaning that is well understood in the art.
- Identifying system is any system capable of correlating a physical entity and information or data related to that physical data.
- An identifying system may have a physical manifestation, such as a bar code or may be only data stored electronically. Thus, while an identifying system must track a physical entity, it need not have a component physically attached to the entity.
- Test concentration refers to the amount of a compound in a given volume of sample that has been prepared for a biological assay.
- Standardized assay concentration refers to a concentration that is within about an order of magnitude of the concentration of a major component extracted from a biological source material when a crude extract of the biological source materials is prepared for biological testing.
- Major component refers to the most prevalent of the potentially selectively biuo-active compounds in a crude extract, at a concentration typically sufficient to (a) exhibit a primary biological activity.
- a typical plant for example, may contain about 10-20 major components, typically 12-15 using conventional screening assays.
- Detectable compound refers to a compound that is detectable by mass spectrometry.
- the present invention relates to a physical array of progeny isolates obtained by fractionating a single biological source, each isolate comprising a concentrated/pure (e.g. >50%) small-medium organic compound (typically not protein or nucleic acid) collected on a physical supporting medium, and associated therewith a data array including the identity of the biological source, the location of each isolate, the fractionation conditions by which each isolate was obtained and preferably physical and/or chemical information regarding the compound, most preferably including its elucidated structure.
- the invention thus provides both a physical/chemical catalog and a data catalog of the organic compounds found in the biological source. These organic compounds may be separated into ultraviolet absorbing and non- ultraviolet absorbing arrays.
- the physical array and the data array each have independent value and usefulness for screening in vitro and "in silico" (virtual screening using computer modeling), but they are most useful when combined.
- the present invention also relates to a physical array of isolate samples wherein each isolate sample comprises a small number of components at or near the standardized assay concentration.
- the small number of components may be less that 100, is preferably less than about 15 and is most preferably no more than about five.
- the isolate sample may be prepared from one or more extracts that have been subjected to one or more chromatography steps.
- Patent selectively bio-active compounds refers to such compounds as described above and elsewhere herein, and typically includes certain classes of organic compounds in the catalog of isolates known to those of skill in the art.
- the classes are broad, and may for example include some or all of the following, or others:
- the solvent is removed by evaporation (under reduced pressure) at less than 40°C until dry
- the dried plant extract is extracted at room temperature repeatedly with the same solvent system or similar solvent system such as ethanol, methanol, ethanol / water, methanol / water,
- the dried plant is agitated in the solvent for preferably eighteen hours, but may be agitated for up to forty-eight hours, (f) the solvent is removed by evaporation under reduced pressure at less than 40°C until dry and combined with the original extract,
- the extraction of the dried extract may be repeated and combined as previously performed with the same or similar or intermediate polarity solvent system selected from the group consisting of ethanol, methanol, ethanol / water, methanol / water, (h) the dried plant extract is extracted at room temperature with a very low polarity solvent system such as hexane,
- the dried plant extract is agitated in the solvent for preferably eighteen hours, but may be agitated for up to forty-eight hours,
- the dried plant extracts are stored in amber glass vials under nitrogen and at -20°C to prevent degradation.
- a feature of the present invention is the ability to simultaneously process a plurality of plant material extracts.
- the plurality of plant materials may be from different plants.
- plant materials P 1 , P2, P3 may originate from the same plant.
- plant material from whole plant and from leaves, stem, and roots may be simultaneously processed and prepared for biological testing.
- three samples, PI, P2, P3, from three different plant segments may be used.
- each of the plurality of plant materials may be extracted with a plurality of solvents.
- each sample of plant material is extracted with at least two different solvent systems to give, for example, highly non-polar extract El and non-polar to polar organic extract E2.
- each of the stem, leaf and root materials may be extracted with a non-polar organic phase such as hexane, and a combination of polar organic phases such as 80% ethanol/water, 50% ethanol / water, and 30% ethanol / water.
- a single parent plant could give rise to a family of extracts generated from different plant sections, each of which is extracted with a plurality of solvents.
- a total of six extracts per plant are obtained. As few as one extract and as many as six may be made from each plant section.
- two extracts are made using two solvent systems, the first having log P > 4, and the second, having log P ⁇ 4.
- the partition coefficient (log P) expresses the lipophilicity of organic molecules. It is the ratio of solubility of a molecule in two immiscible phases such as water and octanol. Though octanol/water is a well established simple membrane model, other solvents can be used. It is a benchmark test to compare solubilities of molecules.
- each of the plurality of extracts obtained may be further processed to remove interferences.
- Each extract may thus be processed to remove polyphenols, tannins, fatty acids, phospholipids, tri-, di-, and monoglycerides as appropriate.
- FIG 2 shows the removal of fatty acids from the highly non-polar extract El, and the removal of tannins from non-polar to polar extracts E2. It will be appreciated that the invention contemplates the removal of any interferences from all extracts as may be appropriate.
- the removal of fatty acids and polyphenols can be combined in a single step if the extract contains both of these classes of compounds. This is accomplished by either stacking the separate appropriate columns listed below or having a layered column made by a solid phase extraction manufacturer.
- the removal of interferences may be performed by the fully automated solid phase extraction procedure described in section C.
- Polyphenols and tannins are ubiquitous in plants and may generally be found in plant extracts prepared with ethyl acetate, ethanol, methanol, ethanol / water, methanol / water, and water.
- the polyphenols and tannins if not removed before biological screening, may result in a false positive or negative or interfere with the mechanisms of the biological assay. Numerous screening groups take the pre-cautionary step of removing these chemicals.
- the present invention similarly uses a polyamide column to remove polyphenols and tannins as shown in FIG 2.
- the plant extract is diluted in a sufficient amount of methanol or ethanol.
- a polyamide packed column 22 as available, for example, from 1ST or Machery Nagel, is washed with a suitable amount of methanol or ethanol and then pre-conditioned with a suitable amount of water.
- the polar plant extract solution from E2 is passed through the column 22 at a suitable flow rate known to those skilled in the art.
- the column is washed with a sufficient amount of methanol.
- the solution is evaporated to dryness to result in reasonably tannin- free plant extracts E2 b . 2. Removal of Fatty Acids, Phospholipids, and Tri-, Di-, and Monoglycerides
- Fatty Acids, Phospholipids, and Tri-, Di-, and Monoglycerides are ubiquitous in plants and may generally be found in plant extracts made with hexane, ethyl acetate, ethanol, and methanol.
- the invention preferably utilizes contemporary solid phase extraction methods to remove the fatty acids, phospholipids, and tri-, di-, and monoglycerides from the lipophilic small cyclical compounds generally of interest in the biological screening of plants.
- FIG 2 is a schematic diagram of the removal of fatty acids and related compounds from the highly non-polar plant extract El b.
- the highly non-polar plant extract El is diluted in a sufficient amount of solvent.
- a non-polar chromatography column 21 is washed with a suitable amount of hexane, ethyl acetate, acetone, methanol or ethanol and then pre-conditioned with a suitable amount of ethanol
- the plant extract solution from El is passed through the column 21 at a suitable flow rate known to those skilled in the art.
- the column is washed with a sufficient amount of hexane, ethyl acetate, methanol, ethanol, or acetone.
- the solution is evaporated to dryness resulting in a reasonably fat-free plant extract Elb.
- the packing material of the column 21 used to remove fatty compounds preferably has a carbon chain long enough to selective interact with the non-polar fatty compounds, but the least amount that is suitable so as to allow smaller and more polar molecules to pass through in a reasonable period of time.
- Preferred materials have C18 or less, preferably less than C8 such as, for example, a C2, C4, C6, or C8 packed column available from 1ST, Machery Nagel and others.
- the removal of interferences may change the total number of extracts produced in the liquid extraction step and may substitute for subsequent solid phase extraction procedures while improving their quality and preparing the material for subsequent processing and screening.
- An object of the present invention is to provide a superior complete method for preparing plant extracts for use in the high throughput screening of biological assays. It is also an object of the present invention to provide chromatographic scheme for the semi-purification and concentration of compounds found in plant extracts specifically for use in high throughput screening biological assays.
- the chromatographic screen described below uses solid phase extraction techniques.
- the apparatus used for automated distribution and solid phase extraction may be of any type capable of simultaneously performing the multiple tasks contemplated by the invention.
- An embodiment of the liquid handling system is shown in FIG 6.
- the various tasks to be performed are shown schematically in FIG 3.
- FIG 3 shows the steps involved for a single extract such as El b or E2 b , however, it is preferred that while each sample is processed individually, the system be capable of conducting the processing of each sample simultaneously.
- treatment of a single extract is shown in FIG 3.
- An individual extract El with interferences removed El is prepared as an extract sample Els for loading onto a column 33.
- This sample preparation process 31 may be performed manually such that the extract sample El s is positioned on a worktable for a sample handling system, or sample preparation may be automated.
- the automated handling system prepares the column 33 for sample by transferring 34 an appropriate solvent or solvents SI, S2, S3, etc. and carrying out washing and any other steps necessary to prepare the column to accept the sample.
- the extract sample El s is then loaded 32 onto the proper column 33.
- the column 33 may be any chromatography column suitable for the separation of components of the sample fractions.
- the column 33 is suitable for solid phase extraction (SPE).
- SPE solid phase extraction
- the highly non-polar extract sample Els is preferably chromatographed using a polar column, a silica column is especially preferred.
- the organic polar extract sample E2 s is preferably chromatographed on nonpolar SPE columns.
- a C8 or CI 8 column is most preferred for the polar organic extract sample E2 s-
- the automated system affects the separation of plant components by accepted chromatographic methods using one or more of solvents SI, S2, S3, etc. transferred 34 to the column 33. Separation may be conducted by use of a single solvent or by using gradient techniques. Although some experimentation may be required for selection of the proper techniques, this selection is routine and well known in the art. Furthermore, because solubility profiles are known for each specific extract sample due to extraction solvent system that extracted it from native plant material, selection of the proper chromatographic technique is easily facilitated. The automated system separates the chromatographed samples into fractions 35.
- Fraction collection criteria may be determined by collection of predetermined volumes of eluent, collection of specific solvent eluents, collection of specific fractions based on a detection system such as a UN detector, or any other predetermined criterion.
- the automated system is sufficient to track each individual sample, including the origin, the separation method and collection criterion used.
- the fractions 35 are distributed in an array on a physical support medium 36 having discrete locations for individual fractions.
- the physical support medium may be, for example a microtiter plate.
- Associated with each fraction sample on the physical support medium, such as with each well of the microtiter plate, is an identifier.
- the identifier may be, for example, a bar code or row and column location.
- the identifiers for each fraction in the array are stored in an associated data array.
- the data array identifies the source of each fraction and all of the conditions used in its preparation such as the column or columns used in removing interferences, the column used for separation, the chromatography conditions, the collection criteria and the physical location of the samples on the support medium.
- a database contains the data arrays and thus form a "shadow” or "fingerprint" of the physical array of fractions.
- the identification system provided by the invention is not limited to storing information regarding the purification of samples, but may be used to correlate other sample information. Such information may relate back to, for example, the taxonomic classification of plant samples or the collection sites of the samples. It is contemplated that the method will be invaluable for biodiversity prospecting, the collection of plants from wild and remote areas and study of the plants for purposes of developing useful natural products. Because reproducibility of results is desired and subsequent sample collection may be required, it is useful if scientists collecting specimens can record exact geographic locations where collection occurred. This may be done, for example, by recording collection positions using global positioning satellite (GPS) systems. Handheld GPS instruments for recording position are readily available. GPS data acquired using these instruments may be stored in the identifier associated with the extracts of the invention and facilitate further collection of raw materials.
- GPS global positioning satellite
- a preferred apparatus is a system for automating the multiple, simultaneous aspiration and dispensing of liquid plant extracts from vials, tubes, or other containers into microtiter plates and solid phase extraction array columns.
- the preferred system includes a robotic sample processor ("RSP") with a fully automated solid phase extraction system and a PosID bar code scanner.
- the preferred solid phase extraction system includes a computer controlled vacuum pump.
- the RSP preferably has a Robotic Manipulator Arm (RoMa), such as that show in FIG 7, that can move microtiter plates around the worktable and assemble and disassemble the entire solid phase extraction system.
- RoMa Robotic Manipulator Arm
- the design features of the RoMa may be a gripper-space range of about 55 to about 140 mm, a rotational angle of about 280°, and force in the Z direction of up to about 35N.
- the RSP is preferably equipped with eight sampling tips, but may be equipped with four sampling tips.
- the sampling tips are arranged on one arm that has independent movement in the Z direction and Y equidistant spreading of about 9 to about 38 mm.
- the versatile design of the sampling tips enables the aspiration and dispensing of liquid plant extracts from vials, tubes, or other containers into narrower microtiter plates and solid phase extraction array columns.
- the robotic sample processor is for example RSP 200/8 Genesis supplied by Tecan U.S., Inc., Research Triangle Park, N.C.
- the operation of the robotic sample processor is controlled by software from a computer which has been programmed to carry out the steps in accordance with the present invention.
- Tecan RSP 200/8 Genesis is preferred, it is understood that other equivalent sample processors can be used or modified to carry out the processing steps and methods in accordance with the present invention.
- the solid phase extraction system is for example Te-VacS supplied by Tecan U.S., Inc., Research Triangle Park, NC.
- Tecan Te-VacS is preferred, it is understood that other equivalent solid phase extraction systems can be used or modified to carry out the processing steps and methods in accordance with the present invention.
- the RSP is preferably equipped with a Positive Identification System, PosID, bar code scanner that can scan all items on the worktable including carriers, racks, vials, tubes, microtiter plates, and all of the accessories of the solid phase extraction system. Other identification systems may be used that perform the same functions.
- the PosID is controlled by a computer which maps the worktable items.
- the PosID develops a map of the dispensed liquid plant extracts onto a physical supporting structure such as the wells of the microtiter plates.
- the software of the computer maps the dispensed extracts and then can export the data map of dispensed liquid extracts to other software packages including spreadsheets and databases. Alternatively, the data maps may be exported into automated systems for further subsequent separation and purification of the fractions.
- the PosID ensures the correct tracking of the individual liquid extracts. The potential for sample handling errors increases with the number of fractions produced, so the PosID is vital to the successful implementation of the present invention.
- vials of the plant extracts are manually loaded into the racks on the worktable of the RSP.
- the appropriate carriers, racks, waste containers, microtiter plates, vacuum manifold, vacuum chamber, and solid phase extraction column array are manually loaded onto the worktable.
- the software program for the fully automated solid phase extraction procedure is initiated to control the sequence of events for the fully automated solid phase extraction.
- Solid phase extraction array columns may consist of silica, amino, diol, C2, C4, C6, C8, C18, and polymeric solid packing material.
- the solid phase extraction system is assembled by the RoMa arm. The sequence begins with washing the column arrays with a strong organic solvent, preferably methanol, for reverse phase and normal phase columns.
- the vacuum is turned on by the software and the liquid is forced through the columns with an appropriate flow rate understood by individuals familiar with the art.
- the vacuum is turned off.
- a weak solvent is added next to the column array, preferably water for reverse phase separations, and hexane for normal phase separations.
- the wash steps are passed to waste.
- the sample is loaded next.
- the eluent is collected in microtiter collection plates from the sample loading and subsequent fraction collections.
- the RoMa arm enables the fraction collection process into microtiter plates to be fully automated.
- a gradient elution strength scheme is used to elute groups of compounds from the columns by increasing solvent strength. For reverse phase separations increasing concentrations of methanol are used.
- the invention includes a purification step that may be used to generate arrays of compounds for testing or may alternatively be used as a subsequent purification step for "hits" or fractions showing desired biological activity.
- the purification step is automated and results in relatively pure compounds.
- "relatively pure” means an isolate that preferably contains a single compound of at least about fifty percent purity and more preferably of at least about ninety percent purity.
- the purification system prepares and individually chromatographs each of the fractions collected from the automated distribution and solid phase extraction system.
- the purification system may simultaneously purify a plurality of fractions on a plurality of one or more different types of columns using a plurality of solvents or solvent systems.
- a fraction from a polar extract may be purified on a non-polar chromatography column using a single solvent elution scheme.
- the purification system also utilizes at least one detector that is used to control fraction collection.
- a multiple wavelength spectroscopic detector may be used that simultaneously detects multiple wavelengths, typically two to eight different wavelengths.
- the detector preferably provides a means for further compound identification or structure elucidation.
- a photodiode array detector may be used to measure spectroscopic properties or mass spectrometry may be used to identify molecular weights of pure compounds.
- FIG 8 and FIG 9 diagrammatically show the fraction collection system and the final contents of the collection plate.
- the further purification is provided by Gilson modular components coupled with a photodiode array detector and Hudson Control Group Robotic Crane.
- a liquid handler 215 comprising eight independent injectors and eight independent valves for dispensing samples controls sample injection.
- Independent drive modules 305 control the delivery of solvent systems for the individual separations.
- the Drive modules 305 control analytic mixers 811C that accept and mix solvents or solvent systems for the individual chromatographies.
- Chromatography is conducted on individual chromatography columns 400.
- the chromatography columns may be of any common type, for example Symmetry Prep CI 8, Prep Nova-Pak HR and Delta-Pak, available from Waters.
- One particular advantage of the Gilson system is the ability to handle numerous chromatographic separations simultaneously.
- each independent column exits through a set of independent photodiode array detectors 170.
- the photodiode array detectors simultaneously digitally record the spectra of isolates and control fraction collectors 204 by monitoring of two to eight different wavelengths.
- the isolates are dispensed into a physical solid support system with discrete locations for isolate collection and storage such as a microtiter plate with wells.
- An identifying system such as the PosID system described above, is associated with the system and correlates data with each isolate.
- the identifier associated with each isolate also includes the conditions used for further purification and the spectrum measured by the photodiode array detector 170. This purification process can be repeated until an acceptable purity has been achieved, as measured by MS, DAD, or other detection mechanism.
- the data associated with the identifying system of each fraction or isolate compiled during a purification step can be automatically accessed by the chromatography data system operating the purification system to determine whether a repeated injection/purification step is required to obtain suitable or enhanced purity.
- the purification system using suitable algorithms, may utilize the separative conditions and other data associated with each isolate to determine the optimal subsequent chromatography conditions for further purification.
- the data system computes the conditions based on the data associated with each isolate or fraction in the data array described above.
- These "check and continue” and “custom chromatography” features can operate at each automatic step of the purification process or after a preset number of separative steps have been performed. In practice, for example, the system will identify the gradient region where multi-compound peaks occur, then run those peaks through separation using a shallower gradient to resolve such peaks into individual peaks.
- the present invention provides a systematic method for providing arrays of plant extracts or isolated pure compounds that are fundamentally different from all known prior art. For example, although prior art methods prepare an ordered array of known target compounds, the invention is fundamentally different in providing an array of unknown, non-target compounds for testing. In addition, although the prior art arrays were generated by isolation or synthesis of single compounds, arrays of the present invention are generated through fractionation of complex mixtures of compounds. Although the identifying system of the invention removes the necessity for preparing orderly arrays, providing for the ordering of the arrays of isolates in a logical manner is preferred. These arrays may be constructed from a wide variety of fractionated plant extracts, but other fractionated natural product extracts or isolated pure compounds, including but not limited to marine organisms, microorganisms, and insects, are within the scope of the invention.
- the invention provides a layout of arrays of isolates in microtiter plates that contain various unknown compounds for screening in biological systems.
- the invention provides that the solubility profile of each isolate is known.
- the arrays are preferably ordered in such a fashion as to expedite collection of the isolates and provide insights into the solubility of the compounds specific to each array. This method has great utility in accelerating the discovery of compounds by providing information about the physical properties of the chemicals in the isolates before the screening process.
- the preferred arrays are constructed from ordered gradient elution schemes developed with consideration of the origin of the solvent fractionated isolate and the solid phase extraction sorbent that may retain compounds in the mixtures.
- Each group of arrays consists of sets of solubility related isolates which may contain approximately one to fifty compounds per isolate with a common solubility profile and various structural diversity when a purification step is included in the method, isolates typically contain one to three compounds.
- These arrays may be arranged in larger groups of arrays consisting of sets of arrays and tested to provide information regarding all of the isolates in the arrays. For example, the larger groups of arrays may originate from different regions of the same plant and be ordered by the plant from which the isolates originate.
- a set of such arrays would thus represent a parent plant and a set of isolates that are the progeny of that plant.
- the collection strategy will depend on the type of chromatography used. With an SPE system having a block of 96 columns, for example, 20 plants may be collected, and four samples from different plant parts prepared, then 2 extracts of each (ethanol and hexane), producing 160 extracts. As 16 of the columns on the column block are for standards, the 80 ethanol extracts are loaded on the 80 sample columns, and the first fraction of each is collected in plate 1. The second fraction is collected in plate 2, the third fraction on plate 3, and so on. The wells corresponding to each sample are the same on each plate. Thus, if there are five fractions, there would be five plates for the ethanol extract, each having 80 samples, and five more plates for the hexane extract, providing a library of isolated compounds from 20 plants on 10 plates.
- the first fraction is collected e.g. in column 2, row A
- the second fraction is collected in plate 1, column 3, row A, and so on until column 11 , row A, then the fractions would be collected in row B from column 11 back to column 2, and so on.
- An extract being separated might have from 5 to 150 compounds that can be separately isolated.
- the collector takes another extract and begins chromatography on that extract, collecting in the well after the last fraction of the previous extract.
- a plate might have the extracts from several plants arrayed on it, or a plant might require several plates to capture all the compounds.
- the array of fractions or isolates thus comprises a large number of individual isolates that are related as being, for example, the progeny of a single plant or originating from a particular taxonomic division of plants.
- the large number of isolates in each array is preferably at least about 10 and most preferably at least 50. It may be larger than the number of wills on a plate, in which case the array includes several plates.
- the number of individual, unique isolates can be represented by M which is a function of P, S, E, F and A in which:
- P is the number of plants used to generate the extract samples
- S is the number of samples obtained from different parts of each plant
- E is the number of solvent extracts taken from each sample
- F is the number of fractions obtained from each solvent extract, the fractions F being obtained by a first chromatography step
- A is the number of subtractions collected from a second chromatography step of each fraction.
- the maximium value of M may be represented as:
- P P x S x E x F x A (1)
- P is defined as the number of plants used to generate an array of isolates. For a particular set of isolates, P is preferably from one to ten and is most preferably one.
- S is the number of samples obtained from each plant. For example, if leaves, stem and root are used, S is three. It is preferred that S be from one to five.
- E is defined as the number of extracts taken from each sample. In a preferred embodiment, E is from one to three. Most preferably, E is two.
- the number F is defined as the number of fractions collected from each extract.
- E is the number of fractions collected by solid phase extraction and is preferably from three to twelve. A most frequently represents the number of fractions collected from the further purification system, when utilized.
- A is assigned the value of one.
- A is from one to twelve.
- E*F*A is greater than 10, more preferably greater than 15.
- P, S, E, F, and A there can be a different number of products. That is, for each plant there can be a different number of samples; for each sample, a different number of extracts; for each extract, a different number of fractions; and for each fraction, a different number of subtractions.
- there may be two solvent extracts (polar and non-polar), one of which produces three fractions and the other of which produces six fractions, for at total of M 9 isolates.
- the ordered arrays of the invention are unique in that (a) they include essentially all of the significant phytochemicals (those having a potential selective bio-activity) because all have been extracted by thorough extraction, and none have been passed to waste due to careful detecting of the chromatography eluent, (b) each well of the ordered array has at least one detected compound (none are blank), and (c) the wells do not have more than a few compounds.
- the array of isolates thus represents a physical catalog of related compounds. Associated with each isolate is a data array. Thus, in addition to the novelty and utility of arrays of isolates, each individual isolate and its associated data is also novel and valuable. Each individual isolate has associated therewith data useful for replicating test results and for the isolation of biologically significant compounds.
- the data array forms a "virtual catalog" of properties that mirrors or shadows the physical array of compounds. Much of the valuable information in the physical catalog is also contained in the virtual catalog. Thus, the data label itself that is associated with each isolate has value, particularly if structural data is associated with such data.
- isolate samples may be packaged on, for example, sample plates wherein each sample on the sample plate contains a small number of detectable compounds.
- the small number of detectable compounds is less than about 100, more preferably is less than about 15 and most preferably is no more than about five.
- a biological source material is extracted with at least one extraction solvent to give one or more extracts.
- the interferences are preferably removed from each extract.
- Each extract is then subjected to at least one automated chromatography as previously described. Fraction collection may be conducted by an automated detection system or by time dependent collection. The individual fractions are then analyzed. Fractions that do not contain detectable compounds may be discarded.
- each isolate sample contains an amount of detectable compounds which, upon preparation for a biological assay, contain the detectable compounds in an amount equal to or greater than the standardized assay concentration.
- fractions that contain detectable compounds in excess of the amount required for preparing a standardized assay concentration may be subdivided into multiple isolate samples and distributed on more than one sample plate.
- Fractions containing an amount less than the amount required for preparing a standardized assay concentration may be combined with other fractions having a similar composition. Using this method, about four to five sets of sample plates may be prepared in a single sequence.
- An application of this invention is the rapid screening of isolates containing compounds that have been semi-purified and concentrated.
- An array of isolates is screened and the optimum isolates may be chosen for further structure elucidation and activity confirmation.
- the invention is extremely powerful primarily for three reasons, 1) chemicals in the plant extracts are semi- purified and concentrated when compared to traditional methods of preparing plant extracts which provides an increased probability of showing biological activity free from interferences and numerous other secondary interactions with other chemicals in the plant extracts, 2) physical property information about the lou chemicals in the plant extracts are provided with each extract which will decrease the time of elucidating the structure; and 3) the physical array of isolates can be used in existing high throughput screening systems developed for synthetic combinatorial chemistry applications, extending these systems to the field of biodiversity prospecting.
- the data labels of the present invention may be independently useful screening tools.
- bioassays for screening of compounds the advent of high speed computers and the wealth of knowledge regarding structure-activity relationships in recent years allows for "virtual screening" of chemical compounds.
- virtual screening a computer analyzes possible structure activity relationships in drug discovery.
- virtual screening provides for "in silico" screening of drug candidates.
- the compound itself is not necessary for in silico screening, only data.
- the invention applies to the business method of accessing an electronic catalog of isolates on a website and searching and purchasing a particular species' frozen tissue and natural product derivatives including total RNA, Poly (A) RNA, DNA, organic compounds, crude liquid extracts, flash chromatography fractionated extracts, and Prep LC fractions for potential scientific or commercial successes. From this website species can be searched, sorted, and/or grouped based on order, family, genus, species, type of derivative or any combination of all of the latter, and relevant information can be manipulated as desired. All of the species have been collected to produce natural product derivatives by extraction, separation, and isolation techniques for distribution to researchers who will greatly benefit from the ability to access all of the individual types of natural product derivatives for species collected in different geographical locations or at different altitudes.
- the invention focuses on allowing scientists, life science researchers, and/or managers to access natural product derivatives of different species to conclude novel relationships unable to have been studied previously because this type of access to natural product derivatives and to the technology was previously not available.
- a researcher can identify a family of plants, review the genuses and species within them, select species of plants within the family, review chemical isolates of the selected plants of the species, and select particular isolates or suites of isolates.
- the method may further entail providing biochemical information about the isolates, such as structure, sequence, or preparative conditions, or providing geographical, temporal, and taxonomic information about the plant, or legal status.
- the method may further involve means for purchasing related biological material products such as particular isolates or isolates of particular plants, e.g.
- One aspect of the invention is preparing the catalog of information with links between all the categories of materials (e.g. regions, families, climates, families, species, extracts, compounds, and related information).
- the data arrays generated during the isolation steps of the invention are particularly useful in generating an ordered catalog of isolates.
- Such information can be linked to gene expression patterns from the same specimen at the same time, and correlations may be made with the profile of chemicals isolated from the same plant specimen. This information will be invaluable in identifying genes whose expression is linked to the biochemical condition of particular plants.
- a principal object of the present invention is to enable a scientist, life science researcher, or manager the ability to identify and order, e.g. via the internet, any natural product derivative from a particular species.
- Another object of the invention is to enable a scientist, life science researcher, or manager the ability to order via the internet any grouping of natural product derivatives from a particular family, genus, and species or country of origin.
- the methods of accessing these natural products and natural product derivatives are superior to anything known to those skilled in the art.
- the classes of organic compounds typically included in the catalog of isolates according to the invention are broad, and may for example include some or all of the following, or others:
- FIG 10-17 are illustrations of proposed webpages which, when viewed in sequence, show an example of a research and purchase transaction according to the business method aspect of the invention.
- FIG 10 is an illustration of an opening page or home page for the website.
- scientists and other researchers may register as collaborators with the owner of the on-line catalog. After registration, the researcher enters a portion of the website reserved for registered collaborators by selecting an appropriate button on the home page as shown in FIG 10. The user is then transferred to a sign-in page on the website.
- FIG 11 is an illustration of a proposed sign-in page.
- FIG 12 is an illustration of a proposed first ordering page. As shown in FIG 12, the registered collaborator selects a means used to index the catalog of isolates. FIG 12 shows selection by Country of origin of the natural product or by Family. It will be understood that the catalog indexing is not limited to these two choices but may include other indexing means, for example, the type of organism (Plant, microorganism, marine organism, etc.), class of compounds if known (Alkaloid, Cardenolide, etc.) or any others.
- FIG 13 is an illustration of a proposed webpage for selection of an isolate by country.
- FIG 13 shows a map indicating the countries from which cataloged isolates are available. The user selects a country of origin and is then transferred to a series of webpages that direct selection of a species within that country.
- FIGs 14-16 are illustrations of proposed webpages that guide the user through the selection process. The user selects the family, genus and species of the plant or organism using the appropriate buttons on the webpages illustrated by FIG 14, FIG 15 and FIG 16, respectively.
- FIG 17 is an illustartion of a proposed webpage for selecting the material.
- a user who is a registered collaborator, may order one or more of a selected number of natural product derivatives. These include isolates generated through the method described herein, but may also include materials generated by other methods yet still associated with a particular species. Thus, it will be appreciated that the derivatives listed on the webpage illustrated in FIG 17 are not comprehensive and additional natural products may be available to users.
- Ethanol Weigh the plant material. Appropriately grind the plant material to a fine powder. Transfer the ground plant material into a 4 L flask. Transfer 1 L of ethanol to the 4 L flask. Agitate for approximately 18 to 22 hours. Pour the ethanol through a low ash filter paper and funnel into an appropriate round bottom evaporator flask. Reduce to approximately 20 ml of liquid at less than 40°C. Turn off heat. Reduce to dryness under vacuum. Final evaporation step must be into an amber scintillation vial with no heat. This is the Ethanol Extract (E2). Weigh the dried extract. Mix the extract thoroughly. Nials are store under nitrogen at - 20°C.
- Hexane Extract Return any insoluble material in the low ash filter paper and funnel to the original 4 L flask. Transfer the ground plant material into a 4 L flask. Transfer 750 mL of hexane to the 4 L flask. Agitate for approximately 18 to 22 hours. Pour the hexane Solution through a low ash filter paper and funnel into an appropriate round bottom evaporator flask. Reduce to approximately 20 ml of liquid at less than 40°C. Turn off heat. Reduce to dryness under vacuum. Final evaporation step must be into an amber scintillation vial with no heat. This is the Hexane Extract (El). Weigh the dried extract. Mix the extract thoroughly. Nials are store under nitrogen at - 20°C.
- Example 2 Example 2
- Nials are stored under nitrogen at - 20°C.
- Hexane Extract Return any insoluble material in the low ash filter paper and funnel to the original 4 L flask. Transfer the ground plant material into a 4 L flask. Transfer 750 mL of hexane to the 4 L flask. Agitate for approximately 18 to 22 hours. Pour the hexane Solution through a low ash filter paper and funnel into an appropriate round bottom evaporator flask. Reduce to approximately 20 ml of liquid at less than 40°C. Turn off heat. Reduce to dryness under vacuum. Final evaporation step must be into an amber scintillation vial with no heat. This is the Hexane Extract (El). Weigh the dried extract. Mix the extract thoroughly. Nials are stored under nitrogen at - 20°C. Example 3
- Ethanol / Ethyl Acetate Prepare a Ethanol / Ethyl Acetate (50:50) solution and mix well.
- a 1 gram polyamide column was prepared by washing with 6 mL of methanol and then 6 mL of water three consecutive times. During the third conditioning step of water, the vacuum and pressure was released to allow the polyamide packing material to soak in water for approximately five minutes. This step allows the intra- hydrogen bonded amide bonds of the polyamide to become exposed and form hydrogen bonds with water.
- the effectiveness of the column at removing tannins was tested as follows. A solution of tannic acid (9 mg/mL) and quercetin (1 mg/mL) was prepared. A 2 mL of sample was loaded onto the column with an appropriate flow ( ⁇ 3 mL/min). 6 mL of water was then passed through the column collected.
- a commercially available alcohol extract of Hawthorne was subjected to automated solid phase extraction by carrying out the following steps. A similar separation may be carried out for samples according to Examples 1, 2 and extracts as described in the detailed description (ethanol/water extraction followed by hexane extraction of the extract), followed by removal of tannins and polyphenols, fatty acids, etc.) as in the detailed description and Example 4.
- Preparation of Ethanol / Water Solvent Prepare an Ethanol/Water (80:20) solution and mix well.
- the automated system loads a different PE onto each column of the 96 column array.
- the respective solvents are washed on the respective columns and subsequent fractions are collected.
- the RoMa removes and adds microplates as needed to collect the subsequent fractions. Each separate fraction is collected in a separate well of each of the following separate microplates.
- Sample Preparation Weigh approximately 100 mg of plant extract a suitable container. Dilute to 10 mg/mL with an appropriate solvent. Note: Plant extracts may be obtained from vials, or from a column of a microtiter plate.
- Fraction Collector Collects fractions in microtiter plates based on set absorbance threshold of 8 wavelengths
- Robotic Arm Adds and removes microtiter plates from the 204 fraction collector Microtiter Plate Hotel: Stores used and empty microplates Example 7
- Figure 18 shows an array 100 of isolates in, for example, a microtiter plate and Liquid Chromatography/Mass Spectral (LC/MS) data obtained for a single isolate.
- LC/MS data include the Evaporative Light Scattering Detection (ELSD) Chromatogram, Total Ion Current (TIC) Chromatogram and mass spectrum (MS) of a single isolate.
- Figure 19 shows TIC MS ES + (Electro Spray/positive ion detection) of typical isolates in an array.
- each isolate contains a relatively small number of compounds, i.e. 5, 4, 2 and 3 compounds in Figures 19A, 19B, 19C, and 19D, respectively.
- mass spectral data for each compound in each isolate has been obtained.
- the data shown in Figures 19A through 19D relates the retention times (Rt) of each peak to the mass /charge ratio (m/z) obtained from the mass spectrum of each peak.
- Figure 20 shows typical LC/MS data obtained when sample isolates are prepared, the Figures include retention time (Rt) and mass spectral (m/z) information.
- Rt retention time
- m/z mass spectral
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU14538/01A AU1453801A (en) | 1999-11-02 | 2000-11-02 | Automated plant extraction method and arrays for high throughput screening |
US11/358,815 US7367933B2 (en) | 1999-11-02 | 2006-02-21 | Screening of chemical compounds purified from biological sources |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16307099P | 1999-11-02 | 1999-11-02 | |
US60/163,070 | 1999-11-02 | ||
US18987200P | 2000-03-16 | 2000-03-16 | |
US60/189,872 | 2000-03-16 | ||
US20963600P | 2000-06-06 | 2000-06-06 | |
US60/209,636 | 2000-06-06 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/115,741 Continuation-In-Part US20030044846A1 (en) | 1999-09-03 | 2002-04-03 | Screening of chemical compounds purified from biological sources |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001033193A2 WO2001033193A2 (en) | 2001-05-10 |
WO2001033193A3 WO2001033193A3 (en) | 2001-10-18 |
WO2001033193A9 true WO2001033193A9 (en) | 2002-05-30 |
Family
ID=27388833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/030195 WO2001033193A2 (en) | 1999-11-02 | 2000-11-02 | Automated plant extraction method and arrays for high throughput screening |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1453801A (en) |
WO (1) | WO2001033193A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9322813B2 (en) | 2009-09-01 | 2016-04-26 | Alltech Associates, Inc. | Methods and apparatus for analyzing samples and collecting sample fractions |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030044846A1 (en) | 2001-04-03 | 2003-03-06 | Gary Eldridge | Screening of chemical compounds purified from biological sources |
DE60117637D1 (en) * | 2001-06-05 | 2006-05-04 | Advanced Gene Technology Corp | Chip with plant extracts on the surface |
JP2005504958A (en) * | 2001-06-27 | 2005-02-17 | ユニゲン・ファーマシューティカルス・インコーポレーテッド | Methods for creating, screening and de-replicating natural product libraries for therapeutic drug discovery |
GB0205184D0 (en) * | 2002-03-06 | 2002-04-17 | Molecularnature Ltd | Process for scavenging phytochemicals |
US6855343B2 (en) * | 2002-05-21 | 2005-02-15 | Advanced Gene Technology, Corp | Method to ascertain the quality of herbs |
CN107941979B (en) * | 2017-11-13 | 2022-07-26 | 舟山市食品药品检验检测研究院 | Method for detecting content of cholesterol oxide in aquatic product |
CN110907568A (en) * | 2019-12-17 | 2020-03-24 | 大连工业大学 | Method for extracting free fatty acid from solid or semisolid food by using matrix solid phase dispersion |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5886155A (en) * | 1997-06-18 | 1999-03-23 | Bioresources International Inc. | Purification of miraculin glycoprotein using tandem hydrophobic interaction chromatography |
EP1027603A2 (en) * | 1997-10-23 | 2000-08-16 | Pharmaprint, Inc. | Pharmaceutical grade ginkgo biloba |
-
2000
- 2000-11-02 WO PCT/US2000/030195 patent/WO2001033193A2/en active Application Filing
- 2000-11-02 AU AU14538/01A patent/AU1453801A/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9322813B2 (en) | 2009-09-01 | 2016-04-26 | Alltech Associates, Inc. | Methods and apparatus for analyzing samples and collecting sample fractions |
Also Published As
Publication number | Publication date |
---|---|
AU1453801A (en) | 2001-05-14 |
WO2001033193A3 (en) | 2001-10-18 |
WO2001033193A2 (en) | 2001-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koparde et al. | Natural products in drug discovery | |
Sharma et al. | Drug development from natural resource: a systematic approach | |
Rollinger et al. | Virtual screening for the discovery of bioactive natural products | |
Harborne | Phytochemical methods a guide to modern techniques of plant analysis | |
Poole | Planar chromatography at the turn of the century | |
US20020068366A1 (en) | Proteomic analysis by parallel mass spectrometry | |
US7367933B2 (en) | Screening of chemical compounds purified from biological sources | |
Camp et al. | Front‐Loading Natural‐Product‐Screening Libraries for log P: Background, Development, and Implementation | |
EP1478447B1 (en) | Process for extracting polar phytochemicals | |
WO2001033193A9 (en) | Automated plant extraction method and arrays for high throughput screening | |
WO2003048396A1 (en) | A method for identifying markers | |
US6500609B1 (en) | Method and apparatus for synthesizing characterizing and assaying combinatorial libraries | |
Lee et al. | Assessing the genetic and chemical diversity of Taraxacum species in the Korean Peninsula | |
Houssen et al. | Isolation of marine natural products | |
Ragunathan et al. | Multispectral detection for gas chromatography | |
Cordell et al. | The dereplication of plant-derived natural products | |
Jonker et al. | Methodologies for Effect‐Directed Analysis: Environmental Applications, Food Analysis, and Drug Discovery | |
WO2003074144A2 (en) | Process for scavenging phytochemicals | |
WO2003074145A1 (en) | Process for extracting non-polar phytochemicals | |
AU777927B2 (en) | Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures | |
Williams et al. | Pesticide residues | |
Quinn | Basics and principles for building natural product–based libraries for HTS | |
Robinson | HPLC: the new King of analytical chemistry? | |
EP1265070B1 (en) | Chip exposing plant extracts on its surface | |
Lepola | Generation and utilisation of natural product library for bioactivity screening and drug discovery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/20-20/20, DRAWINGS, REPLACED BY NEW PAGES 1/20-20/20; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |